Tarsus Pharmaceuticals, Inc. TARS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$48.27M+54.0% | -$66.42M+42.5% | -$81.16M+39.6% | -$91.99M+38.7% | -$104.94M+29.2% | ||
| $799K+12.2% | $822K+24.2% | $812K+13.2% | $812K+13.2% | $712K-12.9% | ||
| $46.76M+60.0% | $41.72M+50.0% | $34.81M+34.4% | $29.98M+26.3% | $29.23M+36.3% | ||
| —— | —— | —— | -$80.87M+34.7% | -$65.89M+50.6% | ||
| $15.09M+661% | $9.86M+529% | $3.57M+139% | $1.95M+22.5% | $1.98M+48.4% | ||
| —— | —— | -$150.96M-20.9% | -$146.22M-88.6% | -$135.04M-599% | ||
| $8.03M-95.6% | $143.39M-7.3% | $144M-16.0% | $142.08M-48.5% | $182.45M-22.0% | ||
| —— | —— | —— | —— | -$15.36M-112% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Tarsus Pharmaceuticals, Inc. generate?
- Tarsus Pharmaceuticals, Inc. (TARS) generated -$96.9M in operating cash flow over the trailing twelve months.
- What is Tarsus Pharmaceuticals, Inc.'s free cash flow?
- After $15.1M of capital expenditures, Tarsus Pharmaceuticals, Inc.'s free cash flow was -$104.4M over the trailing twelve months, down 2.6% year over year.
- Where does Tarsus Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Tarsus Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
